Myriad Genetics (MYGN) Will Present Data on Four New Studies at ASHG Annual Meeting

October 17, 2016 7:06 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Myriad Genetics, Inc. (Nasdaq: MYGN) announced it will present four new studies at the American Society of Human Genetics Annual Meeting being held Oct. 18-22, 2016 in Vancouver, British Columbia. The research being presented highlights the clinical utility of Myriad’s myVision® Variant Classification Program and myRisk Hereditary Cancer gene panel test.

“Precision medicine is dependent on the accuracy of the information being provided to patients, and Myriad’s myVision is the most advanced variant classification program available to determine whether a patient's genetic mutation is benign or deleterious,” said Johnathan Lancaster, M.D., Ph.D, chief medical officer, Myriad Genetic Laboratories. “At ASHG, we are excited to present four new studies, which advance the state of the art of genetic testing and meet the scientific needs of researchers and clinicians.”

Below is a list of the featured presentations at ASHG (#ASHG2016):

Platform Presentations

  • Title: PMS2CL-hybrid Alleles Containing PMS2 Sequence and Other PMS2CL-derived Large Rearrangements: The Importance of Correct Interpretation of Dosage Alteration Analysis in PMS2​.Presenter: Nanda Singh.Date: Thursday, October 20, 2016: 12:00 p.m. PT.Platform: 137, Ballroom C.
  • Title: NGS Facilitates Identification of Retrotransposon Insertional Mutations in Hereditary Cancer Genes.Presenter: Yaping Qian.Date: Thursday, October 20, 2016: 12:45 p.m. PT.Platform: 156, Room 115.

Poster Presentations

  • Title: Characterization of TP53 Sequencing Variants Initially Detected in Peripheral Blood Using Next Generation Sequencing Analysis​.Presenter: Debora Mancini-DiNardo.Date: Wednesday, October 19, 2016: 2:00 – 3:00 p.m. PT.Poster: 781W, Exhibit Hall B.
  • Title: Diagnostic Detection, Characterization & Classification of Partial Single Exon Deletions in Hereditary Cancer Genes​.Presenter: Benjamin Roa.Date: Wednesday, October 19, 2016: 2:00 – 3:00 p.m. PT.Poster: 763W, Exhibit Hall B.

For more information about these presentations, including a complete list of abstracts and presentations, please visit the ASHG website at

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Related Entities

Definitive Agreement

Add Your Comment